Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumab. uri icon

Overview

abstract

  • Cutaneous T-cell lymphoma (CTCL) represents a diagnostic challenge because of its large symptomatic overlap with other common skin conditions such as atopic dermatitis (AD) and psoriasis. Dupilumab has offered promising results in AD treatment; however, concerns exist that its use may exacerbate undiagnosed CTCL. We present a patient with CTCL and concomitant AD who experienced improvement in both CTCL blood involvement and AD following the addition of dupilumab therapy.

publication date

  • September 1, 2020

Research

keywords

  • Dermatitis, Atopic
  • Lymphoma, T-Cell, Cutaneous
  • Skin Neoplasms

Identity

Scopus Document Identifier

  • 85094932418

Digital Object Identifier (DOI)

  • 10.12788/cutis.0066

PubMed ID

  • 33104116

Additional Document Info

volume

  • 106

issue

  • 3